The National Biopharma Mission has been approved by the Cabinet for implementation in May 2017 with a total cost US$ 250 million which is co-funded World Bank 50%.
This Mission is designed in a manner in which it addresses the key components of the vision outlined in the National Missions like “Make in India” and “Startup India” and also aims to take forward the commitments made by DBT in the National Biotechnology Development Strategy.
